Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease

View source ↗

Summary

A clinical trial update describing a head-to-head study of Firsekibart versus Anakinra for Adult-Onset Still's Disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anakinra (anakinra)
  • Firsekibart

Snippet

Sponsor: Ruijin Hospital | Conditions: Still's Disease, Adult-Onset | Status: RECRUITING